Bernard Vandercam

1.4k total citations
18 papers, 772 citations indexed

About

Bernard Vandercam is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Bernard Vandercam has authored 18 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Bernard Vandercam's work include HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers) and Mycobacterium research and diagnosis (3 papers). Bernard Vandercam is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers) and Mycobacterium research and diagnosis (3 papers). Bernard Vandercam collaborates with scholars based in Belgium, Netherlands and United Kingdom. Bernard Vandercam's co-authors include Michel Delmée, Jean‐Luc Gala, Pascal Vannuffel, G. Wauters, J. Gigi, H Ezzedine, V. Avesani, J. L. Michaux, Éric Goffin and Laurence Collette and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Bernard Vandercam

17 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Vandercam Belgium 9 563 329 196 171 88 18 772
A Kureishi Canada 15 263 0.5× 305 0.9× 88 0.4× 166 1.0× 60 0.7× 20 879
Robert L. Penn United States 14 280 0.5× 217 0.7× 76 0.4× 131 0.8× 53 0.6× 31 605
Moon Won Kang South Korea 15 303 0.5× 240 0.7× 91 0.5× 221 1.3× 54 0.6× 34 789
D. Spelman Australia 15 409 0.7× 294 0.9× 193 1.0× 110 0.6× 20 0.2× 25 846
Antonia Kolokathis United States 12 363 0.6× 442 1.3× 69 0.4× 87 0.5× 27 0.3× 15 788
Larry M. Bush United States 15 322 0.6× 184 0.6× 156 0.8× 187 1.1× 25 0.3× 51 785
Maria Bruna Pasticci Italy 15 599 1.1× 618 1.9× 135 0.7× 80 0.5× 26 0.3× 59 936
F. Meunier–Carpentier Belgium 17 689 1.2× 583 1.8× 219 1.1× 99 0.6× 273 3.1× 31 1.3k
Todd Lasco United States 22 877 1.6× 653 2.0× 105 0.5× 162 0.9× 69 0.8× 53 1.4k
Tim Henkel United States 15 784 1.4× 506 1.5× 223 1.1× 179 1.0× 49 0.6× 29 1.4k

Countries citing papers authored by Bernard Vandercam

Since Specialization
Citations

This map shows the geographic impact of Bernard Vandercam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Vandercam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Vandercam more than expected).

Fields of papers citing papers by Bernard Vandercam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Vandercam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Vandercam. The network helps show where Bernard Vandercam may publish in the future.

Co-authorship network of co-authors of Bernard Vandercam

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Vandercam. A scholar is included among the top collaborators of Bernard Vandercam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Vandercam. Bernard Vandercam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gillion, Valentine, Nathalie Demoulin, Bernard Vandercam, & Éric Goffin. (2021). Raoultella planticola peritonitis in a patient undergoing automated peritoneal dialysis 48 hours after sanding a horse trail. SHILAP Revista de lepidopterología. 4(4). 271–275. 1 indexed citations
2.
Belkhir, Leïla, Sylvie Jonckheere, Renaud Lhommel, Bernard Vandercam, & Jean Cyr Yombi. (2012). High FDG uptake on FDG-PET scan in HIV-1 infected patient with advanced disease.. PubMed. 66(6). 419–21. 6 indexed citations
3.
Labriola, Laura, Bernard Vandercam, D. Swinne, & Michel Jadoul. (2009). Successful treatment with voriconazole of prolonged Paecilomyces lilacinus fungemia in a chronic hemodialyzed patient. Clinical Nephrology. 71(3). 355–358. 7 indexed citations
4.
Wauters, G., et al.. (2006). Mycobacterium mucogenicum sepsis in an immunocompetent patient. Journal of Infection. 53(3). e143–e146. 6 indexed citations
5.
Leth, Frank van, et al.. (2005). Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy.. PubMed. 38(3). 296–300. 11 indexed citations
6.
Ballout, Ahmad A., Éric Goffin, Jean Cyr Yombi, & Bernard Vandercam. (2005). Vaccinations for Adult Solid Organ Transplant Recipient: Current Recommendations. Transplantation Proceedings. 37(6). 2826–2827. 34 indexed citations
7.
Derdelinckx, Inge, Kristel Van Laethem, Ann De Roo, et al.. (2004). Prospective collection of data on the prevalence of transmitted resistance in newly diagnosed HIV-infected individuals in Belgium in 2003. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles).
8.
Vandercam, Bernard, et al.. (1999). Cidofovir‐Induced End‐Stage Renal Failure. Clinical Infectious Diseases. 29(4). 948–949. 38 indexed citations
9.
Vannuffel, Pascal, et al.. (1999). Molecular characterization of from and and -based discrimination of staphylococcal species. Research in Microbiology. 150(2). 129–141. 46 indexed citations
10.
Ellis, Michael, David J. Spence, Ben de Pauw, et al.. (1998). An EORTC International Multicenter Randomized Trial (EORTC Number 19923) Comparing Two Dosages of Liposomal Amphotericin B for Treatment of Invasive Aspergillosis. Clinical Infectious Diseases. 27(6). 1406–1412. 183 indexed citations
11.
Staszewski, Schlomo, Veronica Miller, Robert Colebunders, et al.. (1996). Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Antiviral Therapy. 1(1). 43–51. 5 indexed citations
12.
Vandercam, Bernard, et al.. (1996). Low molecular weight proteinuria in human immunodeficiency virus-infected patients. American Journal of Kidney Diseases. 27(6). 803–808. 50 indexed citations
13.
Vannuffel, Pascal, J. Gigi, H Ezzedine, et al.. (1995). Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. Journal of Clinical Microbiology. 33(11). 2864–2867. 250 indexed citations
14.
Vandercam, Bernard, et al.. (1992). HIV infection and rape.. PubMed. 60(2). 77–81. 3 indexed citations
16.
Delmée, Michel, Bernard Vandercam, V. Avesani, & J. L. Michaux. (1987). Epidemiology and prevention ofClostridium difficile infections in a leukemia unit. European Journal of Clinical Microbiology & Infectious Diseases. 6(6). 623–627. 63 indexed citations
17.
Vandercam, Bernard, et al.. (1987). Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.. PubMed. 52. 65–78. 60 indexed citations
18.
Vandercam, Bernard, et al.. (1985). Hypercalcemie Hypocalciurique Familiale Reconnue Avant Toute Cervicotomie Erronee. Acta Clinica Belgica. 40(4). 220–229. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026